Benzene

Benzene

SCHEMBL2355019

CCCCCCc1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.71
▸ SIGMAR1 Q99720 6/20 0.62
▸ ESR1 P03372 2/20 0.61
▸ ADRA2A P08913 2/20 0.61
▸ ADORA3 P0DMS8 2/20 0.61
▸ TACR2 P21452 2/20 0.61
▸ SLC6A2 P23975 2/20 0.61
▸ SLC6A4 P31645 2/20 0.61
▸ SLC6A3 Q01959 2/20 0.61
▸ HTR2A P28223 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ SHBG P04278 1/20 0.61
▸ TP53 P04637 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ HSPD1 P10809 1/20 0.61
▸ ADRB3 P13945 1/20 0.61
▸ HTR2C P28335 1/20 0.61
▸ HSPE1 P61604 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL8518570 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL33437 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL8679386 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL4932286 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL8678550 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
Benzene SCHEMBL8518614 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL1619768 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL29401 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL1331102 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3
SCHEMBL8614349 1.00 KCNH2 (0.71) KCNH2SIGMAR1ESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536683-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY AROMATIC NUCLEOPHILIC SUBSTITUTION Centre National De La Recherche Scientifique (FR) 2012-12-26 — — EP disclosed
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP UNIVERSITE DU MAINE (FR) 2012-12-13 — — US disclosed
WO-2011101599-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY AROMATIC NUCLEOPHILIC SUBSTITUTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-08-25 — — WO disclosed
EP-0650956-B1 Triphenylamine derivatives, and charge-transporting materials and electrophotographic photoreceptors containing such derivatives TAKASAGO PERFUMERY CO LTD (JP) 1998-07-15 — — EP disclosed
US-5573878-A HIGH CHARGING POTENTIALS, HIGH CARRIER MOBILITY TAKASAGO INTERNATIONAL CORPORATION (JP) 1996-11-12 — — US disclosed
US-5567560-A Triphenylamine derivative charge-transporting material containing electrophotographic photoreceptor TAKASAGO INTERNATIONAL CORPORATION (JP) 1996-10-22 — — US disclosed
EP-0650956-A1 Triphenylamine derivatives, and charge-transporting materials and electrophotographic photoreceptors containing such derivatives Takasago International Corporation (JP) 1995-05-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP COMT, NAA15, NUDC KCNH2 110/4885SIGMAR1 2470/4885ESR1 1025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback